Home Study Details

    Program Type

    Live Webinar


    1.5 Contact Hour(s)

    Release Date

    Tuesday, February 16, 2021

    Offline Date

    Friday, February 16, 2024

    ACPE Expiration Date

    Friday, February 16, 2024

    Target Audience




    • Overview

      On average in our country, one person dies every 7 minutes from a drug overdose. Thus, over the course of the 21.5 hours of continuing education available in the “Pain Management Specialty Pharmacist” 
      (PMSP) Certificate Training, more than 184 people will die of a drug overdose. And to think, those statistics come from before the COVID Pandemic, which has flooded our country with report after report of increased drug overdose deaths. That being said, those statistics account for all drugs, not solely opioids, and certainly not only prescription opioids. In fact, current drug overdose death trends are significantly concentrated within the illicit substance realm. However, as healthcare professionals, 
      (especially as pharmacists, the stereotyped “drug experts”), we absolutely need to realize that we have an indirect hand in the overall drug supply chain. Thus, our discussion in this presentation will highlight many avenues for change that can make a difference in many lives. If there is change in even one patient’s life, this program will be a success.

      Every single day in our country, and across the globe, headline after headline covers the “Opioid Crisis,” “Opioid Epidemic,” or, perhaps better stated, the “Opioid Pandemic.” However, do we as healthcare professionals have a firm understanding of the multitude of dynamic intrigues of providing high quality pain management patient care? One may ask, “Just how did we get this far in the Opioid Crisis?” or “Just what pain management treatment options do my patients have besides opioid medications?” Even, “How do I help my patients that I have simply inherited from other pharmacies?” 

      We, as pharmacists, are the keystone to combating the opioid crisis, while also compassionately and clinically taking care of our numerous patients in pain. Many pharmacists faced with patient satisfaction scores, countless prescriptions and medication orders to verify, and just not enough hours in a given day have cried out for more education and training in pain management, which is one of the pillars of healthcare across the globe today.  Our patients simply deserve more, and our careers can grow exponentially with additional training, thus I look forward to our discussion of “Pain Management in the Opioid Crisis.”


      • Slide Document :   21005L08_2pp.pdf
      • Slide Document :   21005L08_6pp.pdf

      Financial Support By

    • Pharmacist

      Calculate prescription opioid morphine milligram equivalent (MME) daily dosages based on the 2016 CDC Chronic Pain Opioid Guidelines.
      Recognize how the relative risks of opioid overdoses/deaths correlate with the use of identified higher risk prescription opioid dosage thresholds.
      Describe the pathophysiology behind substance use disorder, commonly referred to as addiction (e.g., opioid addiction).
      Recall all of the available abuse-deterrent formulation (ADF) opioid medications, with particular attention to the select few that are both FDA approved specifically as ADF opioid medications and available on the U.S. market.
    • Activity Type


      CE Broker


      Universal Activity Number

      Pharmacist 0798-0000-21-005-L08-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones

    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Firefox 3.0.3 or higher

    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).